




Научные результаты биомедицинских исследований. 2020;6(4):466-475 






Bioinformatic analysis of microduplications  
at 5p15.33: identification of TPPP  







, Svetlana G. Vorsanova
1,2 












Mental Health Research Center, 
34 KashirskoeShosse, Moscow, 115522, Russia 
2 
Academician Y.E. Veltishchev Research Clinical Institute of Pediatrics, 
Pirogov Russian National University,  
2 Taldomskaya St., Moscow, 125412, Russia
 
3 
Russian Medical Academy of Continuous Postgraduate Education,  
bld. 1, 2/1 Barrikadnaya St., Moscow, 125993, Russia 




Background: Autism is a common psychiatric disorder in children. Since autism is a 
multifactorial disease, the genetic predisposition plays a significant role in the patho-
genesis. However, numerous studies focused on genomic abnormalities in autism are 
unable to provide reproducible information about pathogenic processes causing this 
devastating disorder. The aim of the study: Theidentification of candidate genes by bi-
oinformatic analysis of recurrent copy number variations (CNV) (5p15.33 duplications) 
revealed by molecular karyotyping in a clinical cohort. Materials and methods: Mo-
lecular karyotyping of 296 children with idiopathic autism, intellectual disability was 
performed by SNP-array. Bioinformatic analysis was made using an original algorithm. 
Results: Molecular karyotyping genome-wide analysis revealed 3 cases of 5p15.33 du-
plications. Bioinformatic analysis identified a candidate gene TPPP for brain dysfunc-
tion. TPPP is highly expressed in the brain; the gene encodes a protein catalyzing tubu-
lin polymerization, which is important for oligodendrocytes myelination. Interactome 
analysis was performed to identify pathogenic processes associated with CNV involving 
TPPP. Expanded TPPP interactome network encompasses 37 proteins, 19 of which are 
associated with the synaptic plasticity and axonal guidance involved in the normal de-
velopment and functioning of the brain. Changes in these processes may lead to autism 
and intellectual disability. Interestingly, clinical genetic databases have not previously 
associated this gene with a disease condition. Conclusion: Bioinformatic analysis of 
5p15.33 CNV allowed us to show that TPPP is a candidate gene for alterations to the 
development and functioning of the brain. Accordingly, possible disease mechanisms 
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leading to the development of autism with intellectual disability have been proposed. 
Since data on candidate processes is useful for personalized treatment, we conclude that 
molecular karyotyping complemented by our original in silico analysis of epigenome, 
proteome and metabolome is to become an important component for basic and applied 
research in psychiatric genetics. 
Keywords: copy number variants; chromosome 5; bioinformatics; molecular karyotyp-
ing; TPPP; autism; intellectual disability 
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Introduction. Autism spectrum disor-
ders and intellectual disability are common in 
children and adolescents. Average incidence 
of autism varies from 1 to 10 cases per 1000 
individuals around the world [1, 2]. The main 
symptoms of autism include speech and 
communication abnormalities, impaired social 
adaptation, motor function alterations, and 
stereotypies. Autism research shows that ge-
netic predisposition plays a significant role in 
the etiology [3]. Autism may be associated 
with large chromosomal aberrations (2-10%), 
copy number variations (CNV) (5-15%) [3-5], 
and single-gene mutations (5-10%) [4]. In to-
tal, genomic pathology affects no less than 
25-35% of patients with autistic disorders. 
However, focusing on autism predisposition 
genes is limited to expanding the list of can-
didates. Available data indicate high hetero-
geneity and low penetrance of mutations as-
sociated with this disease. Moreover, there are 
speculations about reducing autism risks by 
variations in a number of genes. Apparently, 
autism is not associated with single genes, but 
with a variety of molecular and cellular pro-
cesses [3, 6, 7]. Determining the mechanism 
underlying the pathogenesis of autism repre-
sents an important area of biological psychia-
try and medical genetics. Consequently, bio-
informatic analysis of genomic variations in 
individuals with autism and/or intellectual 
disability to uncover altered molecular and 
cellular processes is a significant step forward 
for unraveling mechanisms of the disease and 
providing the evidence-based therapeutic op-
portunities. 
Aim of the study. Here, we have at-
tempted to characterize microduplications 
(large CNV) affecting chromosome 5p15.33 
by a bioinformatics analysis of molecular 
karyotyping data.  
Materials and methods. Among 296 
children with autism, intellectual disability 
and congenital malformations/developmental 
delays (age: 2-13 years (average age: 5.5 
years); sex ratio: 128/168 (females/males) or 
1/1.3), three individuals have been found to 
demonstrate CNV manifesting as duplications 
at 5p15.33. Duplications encompassed same 
genomic loci in three children with autism 
and intellectual disability. All three children 
had been diagnosed to have autism, intellec-
tual disability and developmental delays. Mo-
lecular karyotyping using Affymetrix Cy-
toScan HD Arrays platform has been per-
formed with an average resolution of ~1000 
bp. In silico analysis of the phenotype out-
come has been performed using original bio-
informatic techniques allowing modulating 
consequences of genome imbalances at tran-
scriptome, proteome and metabolome levels. 
The technique has been previously described 
in details [8-11]. 
Results and discussion. Clinically, all 
three children demonstrated an idiopathic au-
tism assessed by the Child Autism Rating 
Scale (CARS) and intellectual disability. In 
addition to autistic traits, two children had 
congenital anomalies. The first patient had a 
hydrocephalic shape of the skull, lowered 
outer corners of palpebral fissures. The se-
cond had severe microcephaly, a triangular 
face, wide distal finger phalanges, protruding 
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and corpus callosum hypoplasia. The third 
child demonstrated exclusively wavy hair, 
which was not observed in other members of 
his family.  
The first patient exhibited 5p15.33 du-
plication (genomic location: 448542-676847, 
size: 228305 bp) affecting 7 genes: EXOC3, 
PP7080, SLC9A3, MIR4456, LOC100996325, 
CEP72, TPPP. The second patient demon-
strated 5p15.33 duplication (genomic loca-
tion: 448542-819920), size 371378 bp) affect-
ing 8 genes: EXOC3, PP7080, SLC9A3, 
MIR4456, LOC100996325, CEP72, TPPP, 
ZDHHC11. The third patient showed 5p15.33 
duplication (genomic location: 448542-
1175479, size: 726937 bp) affecting 14 genes: 
EXOC3, PP7080, SLC9A3, MIR4456, 
LOC100996325, CEP72, TPPP, ZDHHC11, 
BRD9, TRIP13, MIR4635, NKD2, SLC12A7, 
LOC100506688. Further characteristics of the 
duplications are given in Figure 1 and Table 
1. No other detectable CNV have been associ-




Fig. 1. Duplications at chromosome 5p5p15.33 detected in three cases of autism and intellectual 
disability (https://genome.ucsc.edu GRCH37/hg19) 
 
Table 1 
5p15.33 duplications: localization, size and genes 
№ 
Localization Size Genes 
Chromosomal  Genomic   
1 5p15.33 448542-676847 228305 EXOC3, PP7080, SLC9A3, MIR4456, 
LOC100996325, CEP72, TPPP 
2 5p15.33 448542-819920 371378 EXOC3, PP7080, SLC9A3, MIR4456, 
LOC100996325, CEP72, TPPP, ZDHHC11 
3 5p15.33 448542-1175479 726937 EXOC3, PP7080, SLC9A3, MIR4456, 
LOC100996325, CEP72, TPPP, ZDHHC11, BRD9, 
TRIP13, MIR4635, NKD2, SLC12A7, 
LOC100506688 
 
Regardless of differences in length of 
duplications and the number of affected 
genes, the overlapping region exists. It is im-
portant to note that distal breakpoint is the 
same in all three cases. Since 
CNV/duplications result from alterations to 
recombination, replication, and DNA repair in 
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gest a recombination hotspot localized at 
5p15.33.  
Previously, essential genetic process-
es/changes mediating brain diseases were de-
fined as those occurring directly in cells of the 
diseased brain [14, 15]. Therefore, in silico 
gene expression analysis may provide infor-
mation for prioritizing candidate 
genes/processes for brain dysfunction [9]. Our 
analysis has demonstrated that TPPP has the 
highest expression in the brain as to remain-
ing duplicated genes. Moreover, the relative 
expression is increased in almost all analyzed 
areas of the brain (Fig. 2). 
 
Fig. 2. Expression profiles of duplicated genes in various brain areas (http://biogps.org [35]) 
 
The first duplication affected exons 3 
and 4 of TPPP, which encode phosphorylated 
protein domains, which are involved in the 
regulation of the protein activity. In the se-
cond and third cases, TPPP is completely du-
plicated. The gene has 4 exons and encodes a 
protein catalyzing the polymerization of tubu-
lin, a component of microtubules. Microtu-
bules are essential components of cellular 
processes, such as intracellular transport and 
cell division (chromosomal disjunction in mi-
tosis and meiosis). In addition, microtubules 
play a role in myelination of oligodendrocytes 
[16, 17]. Previously, possible roles of TPPP 
in the development of neuropsychiatric disor-
ders in children have been suggested [9]. Tak-
ing these data into account, TPPP has been 
associated with autism and intellectual disa-
bility. 
To gain further insights into mecha-
nisms of phenotypic outcomes of the duplica-
tions, an interactome analysis was carried out. 
As a result, TPPP was found to interact with 7 
proteins: SCNA, GAPDH, CDK5, CDK5R1, 
TMED3, LIMK1, ROCK1 (Fig. 3). These are 
involved in cell cycle regulation, metabolism, 
and development of the nervous system. Fig-
ure 3 shows TPPP interactome.  
To describe ontologies associated with 
alterations to the interactome due to TPPP 
duplications, a brief overview of proteins in-
volved in this network is given. 
— SNCA (alpha-synuclein) protein belongs to 
the synuclein family. SNCA expression is 
high in brain cells. Alpha-synuclein is as-
sociated with the membrane of vesicles in 
neurons. The protein is involved in the 
control of the transport to presynaptic 
membrane. SNCA is associated with Park-
inson's disease [18]. 
— GAPDH (glyceraldehyde-3-phosphate de-
hydrogenase) is an enzyme required for 
oxidative phosphorylation. It is involved in 
the nitrosylation of nuclear proteins and 
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Fig. 3. TPPP protein interactome generated using STRING [36] 
 
 
— Cyclin-dependent kinase 5 (CDK5) — un-
like other members of the cyclin-dependent 
kinase family the protein does not directly 
regulates of cell cycle. Instead, CDK5 is 
associated with synaptic plasticity and neu-
ronal migration. This enzyme phosphory-
lates proteins. The phosphorylation is in-
volved in regulation of cytoskeleton, endo-
cytosis, exocytosis, and apoptosis. CDK5 
expression is increased in postmitotic cells 
of the central nervous system [20]. 
— CDK5R1 (p35) is a neuron-specific activa-
tor of the cyclin-dependent kinase CDK5 
by calpain-based proteolytic cleavage of 
p35 to form the p25 form. CDK5-p25 
complexes cause changes in kinase struc-
ture and activity [21]. 
— TMED3 (transmembrane protein p24 con-
taining domain 3) is encoded by TMED3, a 
gene, which is not indexed in the OMIM 
database [22]. 
— LIMK1 regulates actin remodeling by 
phosphorylating cophilin and converting it 
into an inactive form. This rearranges den-
drite spines and axon modifications to 
form synaptic plasticity [23]. 
— ROCK1 (serine/threonine kinase) is a Rho-
associated kinase activated by binding be-
tween Rho and guanosine triphosphate 
(GTP). This protein is involved in biopro-
cesses mediated by modification of the ac-
tin cytoskeleton and formation of actomyo-
sin complexes [24]. 
Apparently, LIMK1 and ROCK1 are 
involved in pathways of axonal guidance and 
cytoskeleton regulation. These pathways play 
a key role in the formation and functioning of 
the nervous system [25, 26]. The improper 
regulation causes a decrease in the viability 
and functional activity of cells, and leads to 
genomic (chromosomal) instability, which is 
an element of pathogenic cascades in a wide 
spectrum of brain diseases [27-29]. Interac-
tome analysis shows that TPPP is involved in 
brain development and functioning. There-
fore, TPPP copy number changes leading to 
altered gene dosage may have negative effects 
on neurodevelopmental diseases (i.e. autism 
and intellectual disability). 
Expanded interactome analysis was car-
ried out to highlight ontologies or candidate 
processes for neurodevelopmental abnormali-
ties associated with 5p15.33 duplications. As 
a result, 37 proteins were found to interact 
with TPPP: CDK5R1, GAPDH, SNCA, 
LIMK1, TMED3, ROCK1, CDK5, RHOA, 
CCND2, CABLES1, UBC, FYN, ENO1, 
MAPT, SNCAIP, PARK2, SLC6A3, 
CDK5R2, NDEL1, PPP1R1B, RAC1, APP, 
CDC42, MSN, CSNK2A1, RND3, PGK2, 
HSPA4, RPL13A, PARK7, CCNB1, LRRK2, 
CDKN1B, DPYSL2, AMPH, MYH14, 









Fig. 4. Expanded TPPP interactome generated using STRING (for more details, see https://string-
db.org [36]) and selected ontologies or candidate processes marked by colored semitransparent 
shapes (asterisks indicate proteins involved in the pathways to neurodegenerative diseases) 
 
 
According to the largest ontologies, pro-
teins were clustered as follows: proteins asso-
ciated with the glycolysis enzymes, structural 
and functional proteins of synaptic connec-
tions, proteins involved in actin polymeriza-
tion and axonal guidance; proteins regulating 
cell cycle proliferation and cell differentiation 
(Fig. 4). It should be taken into account that 
proteins may be simultaneously involved in 
several processes. Consequently, we have 
clustered proteins according to ontologies rel-
evant to brain development and functioning. 
The proteins of synaptic plasticity (I) and ax-
onal guidance (II) are of the interest in the 
context of brain dysfunction. The first group 
includes APP, SLC6A3, PPP1R1B, TMED3, 
SNCA, AMPH, and the second group includes 
CDKN1B, CDK5R1, CDK5R2, LIMK1, 
DPYSL2, CDK5, NDEL1, MYH14, RND3, 
MAPT, CABLES1, MSN, ROCK1. According 
to the literature, a large number of autism-
associated genes encode proteins involved in 
synaptic plasticity [30]. Axonal guidance is a 
key mechanism for the development of brain 
structures during brain development. Genes 
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are occasionally mutated in autism and intel-
lectual disability [31-34]. It should be noted 
that 12 out of 37 proteins of the expanded 
TPPP interactome (GAPDH, HSPA4, 
PARK7, PARK2, LRRK2, CDK5R2, MAPT, 
CDK5, APP, SNCA, SLC6A3, PPP1R1B) are 
elements of the neurodegeneration pathway 
(Fig. 4, marked with asterisks). 
Conclusion. We report on an in silico 
analysis of functional consequences of 
5p15.33 microduplications in 3 children with 
autism and intellectual disability. Using an 
original in silico technology modulating phe-
notypic outcomes of CNV (CNV prioritiza-
tion) at transcriptome, proteome and metabo-
lome levels, we have found that TPPP is a 
candidate gene for autism with intellectual 
disability. Additionally, we have been able to 
propose a number of candidate processes for 
neurodevelopmental abnormalities in individ-
uals with 5p15.33 duplications encompassing 
TPPP. These data are intrinsically useful for 
forthcoming efforts in developing personal-
ized therapeutic strategies for neurodevelop-
mental diseases mediated by CNV. 
Knowledge about consequences of genomic 
variations generated by identifying candidate 
processes based on in silico analysis of tran-
scriptome, proteome and metabolome is an 
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